We used rabbit polyclonal antibodies (Abs) recognizing Bax (N20; Santa Cruz Biotechnology, Tebu-Bio, Le Perray en Yvelines, France); Bid and procaspase-9 (BD PharMingen, Heidelberg, Germany); caspase-3 and caspase-9 active fragments (Cell Signaling, Ozyme, Montigny le Bretonneux, France); PARP1 (Boehringer Mannheim, Indianapolis, IN); NF-κB p65, procaspase-3, Fas, and I-κBα (Santa Cruz Biotechnology); mouse monoclonal Abs that recognize actin (Sigma-Aldrich, St. Quentin Fallavier, France); caspase-8 (MBL; Cliniscience, Montrouge, France); caveolin 2 (clone 65; BD Transduction Laboratories, Lexington, KY); cytochrome
c, RIP1, and FADD (BD PharMingen); Hsc70 (Santa Cruz Biotechnology); mitochondrial Hsp70 (Alexis, Läufelfingen, Switzerland); TFF1 (P2802; kindly provided by MCR, INSERM, IGBMC, Strasbourg, France); and XIAP (SressGen, Tebu, Le Perray en Yvelines, France). We also used the IAP inhibitor embelin (Calbiochem, San Diego, CA) and the fluorogenic substrates Ac-DEVD-AMC, which mimics the preferred target site of caspase-3 and -7, Ac-LEHD-AFC, which mimics the preferred target site of caspase-9, and z-IETD-AMC, which mimics the preferred target site of caspase-8 (Biomol, Plymouth Meeting, PA). AMC (7-amino-4-methylcoumarin) and AFC (7-amino-4-trifluoro-methylcoumarin) released from the substrate were excited at 380 and 400 nm to measure emission at 460 and 505 nm, respectively. Caspase activities were measured as initial velocities expressed as relative intensity per minute per milligram.
17 Protein concentrations in cell lysates were determined with the use of a protein assay kit (DC; Bio-Rad, Ivry sur Seine, France).